17-[2-(2-amino-6-oxo-2,3,4,5,7,8-hexahydro-1H-purin-9-yl)phenyl]-23,24,25-trihydroxy-4-(2-hydroxyethoxy)-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaene-6,13-dione

C36H39N5O11 — CID 163150674

IUPAC17-[2-(2-amino-6-oxo-2,3,4,5,7,8-hexahydro-1H-purin-9-yl)phenyl]-23,24,25-trihydroxy-4-(2-hydroxyethoxy)-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaene-6,13-dione
SMILESNC1NC(=O)C2NCN(c3ccccc3C3CCOCC4OC(Oc5c3cc3c(c5OCCO)C(=O)c5ccccc5C3=O)C(O)C(O)C4O)C2N1
InChIInChI=1S/C36H39N5O11/c37-36-39-33-25(34(48)40-36)38-15-41(33)22-8-4-3-5-17(22)16-9-11-49-14-23-28(45)29(46)30(47)35(51-23)52-31-20(16)13-21-24(32(31)50-12-10-42)27(44)19-7-2-1-6-18(19)26(21)43/h1-8,13,16,23,25,28-30,33,35-36,38-39,42,45-47H,9-12,14-15,37H2,(H,40,48)
InChIKeyNFLLYNCSVOAHHJ-UHFFFAOYSA-N
MW717.73 g/mol
LogP-1.40
Rot. Bonds5

About 17-[2-(2-amino-6-oxo-2,3,4,5,7,8-hexahydro-1H-purin-9-yl)phenyl]-23,24,25-trihydroxy-4-(2-hydroxyethoxy)-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaene-6,13-dione

17-[2-(2-amino-6-oxo-2,3,4,5,7,8-hexahydro-1H-purin-9-yl)phenyl]-23,24,25-trihydroxy-4-(2-hydroxyethoxy)-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaene-6,13-dione (PubChem CID 163150674) has the molecular formula C36H39N5O11 and a molecular weight of 717.73 g/mol. Its IUPAC name is 17-[2-(2-amino-6-oxo-2,3,4,5,7,8-hexahydro-1H-purin-9-yl)phenyl]-23,24,25-trihydroxy-4-(2-hydroxyethoxy)-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaene-6,13-dione.

Molecular Properties

Compound Name17-[2-(2-amino-6-oxo-2,3,4,5,7,8-hexahydro-1H-purin-9-yl)phenyl]-23,24,25-trihydroxy-4-(2-hydroxyethoxy)-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaene-6,13-dione
PubChem CID163150674
Molecular FormulaC36H39N5O11
Molecular Weight717.73 g/mol
Exact Mass717.26
IUPAC Name17-[2-(2-amino-6-oxo-2,3,4,5,7,8-hexahydro-1H-purin-9-yl)phenyl]-23,24,25-trihydroxy-4-(2-hydroxyethoxy)-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaene-6,13-dione
SMILESNC1NC(=O)C2NCN(c3ccccc3C3CCOCC4OC(Oc5c3cc3c(c5OCCO)C(=O)c5ccccc5C3=O)C(O)C(O)C4O)C2N1
InChIInChI=1S/C36H39N5O11/c37-36-39-33-25(34(48)40-36)38-15-41(33)22-8-4-3-5-17(22)16-9-11-49-14-23-28(45)29(46)30(47)35(51-23)52-31-20(16)13-21-24(32(31)50-12-10-42)27(44)19-7-2-1-6-18(19)26(21)43/h1-8,13,16,23,25,28-30,33,35-36,38-39,42,45-47H,9-12,14-15,37H2,(H,40,48)
InChIKeyNFLLYNCSVOAHHJ-UHFFFAOYSA-N
XLogP-1.40
TPSA234.40 Ų
H-Bond Donors8
H-Bond Acceptors15
Rotatable Bonds5
Heavy Atoms52
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500717.73
LogP ≤ 5-1.40
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quinone_A(370)', 'substructure': 'N/A'}

Analyze 17-[2-(2-amino-6-oxo-2,3,4,5,7,8-hexahydro-1H-purin-9-yl)phenyl]-23,24,25-trihydroxy-4-(2-hydroxyethoxy)-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaene-6,13-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 17-[2-(2-amino-6-oxo-2,3,4,5,7,8-hexahydro-1H-purin-9-yl)phenyl]-23,24,25-trihydroxy-4-(2-hydroxyethoxy)-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaene-6,13-dione?
The IUPAC name of 17-[2-(2-amino-6-oxo-2,3,4,5,7,8-hexahydro-1H-purin-9-yl)phenyl]-23,24,25-trihydroxy-4-(2-hydroxyethoxy)-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaene-6,13-dione (CID 163150674) is 17-[2-(2-amino-6-oxo-2,3,4,5,7,8-hexahydro-1H-purin-9-yl)phenyl]-23,24,25-trihydroxy-4-(2-hydroxyethoxy)-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaene-6,13-dione.
What is the SMILES notation for 17-[2-(2-amino-6-oxo-2,3,4,5,7,8-hexahydro-1H-purin-9-yl)phenyl]-23,24,25-trihydroxy-4-(2-hydroxyethoxy)-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaene-6,13-dione?
The canonical SMILES for 17-[2-(2-amino-6-oxo-2,3,4,5,7,8-hexahydro-1H-purin-9-yl)phenyl]-23,24,25-trihydroxy-4-(2-hydroxyethoxy)-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaene-6,13-dione is NC1NC(=O)C2NCN(c3ccccc3C3CCOCC4OC(Oc5c3cc3c(c5OCCO)C(=O)c5ccccc5C3=O)C(O)C(O)C4O)C2N1.
What is the InChIKey of 17-[2-(2-amino-6-oxo-2,3,4,5,7,8-hexahydro-1H-purin-9-yl)phenyl]-23,24,25-trihydroxy-4-(2-hydroxyethoxy)-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaene-6,13-dione?
The InChIKey is NFLLYNCSVOAHHJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C36H39N5O11/c37-36-39-33-25(34(48)40-36)38-15-41(33)22-8-4-3-5-17(22)16-9-11-49-14-23-28(45)29(46)30(47)35(51-23)52-31-20(16)13-21-24(32(31)50-12-10-42)27(44)19-7-2-1-6-18(19)26(21)43/h1-8,13,16,23,25,28-30,33,35-36,38-39,42,45-47H,9-12,14-15,37H2,(H,40,48).
What are the key properties of 17-[2-(2-amino-6-oxo-2,3,4,5,7,8-hexahydro-1H-purin-9-yl)phenyl]-23,24,25-trihydroxy-4-(2-hydroxyethoxy)-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaene-6,13-dione?
17-[2-(2-amino-6-oxo-2,3,4,5,7,8-hexahydro-1H-purin-9-yl)phenyl]-23,24,25-trihydroxy-4-(2-hydroxyethoxy)-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaene-6,13-dione has a molecular weight of 717.73 g/mol, XLogP of -1.40, 5 rotatable bonds, 8 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 17-[2-(2-amino-6-oxo-2,3,4,5,7,8-hexahydro-1H-purin-9-yl)phenyl]-23,24,25-trihydroxy-4-(2-hydroxyethoxy)-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaene-6,13-dione is sourced from PubChem (CID 163150674), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).